< Back to latest news & events

Event

German Biotechnology days 2021

August 2021

Event date: 20th September 2021

HGF’s Partner Dr Markus Zoller is attending and speaking at the German Biotechnology days on 20th September 2021.

German Biotechnology days is the go to event in the industry and is considered the German class reunion for biotechnology. It attracts entrepreneurs, scientists and partners from politics, funding institutions and administration. Speakers will discuss diverse fields of application and the potential of biotechnology, from health research to bioeconomy, from medicine to industrial production to plant breeding.

HGF’s Partner Dr Markus Zoller and Dr Thomas Tiller (MorphoSys AG) will be holding a luncheon session on 20th September, where they will cover ‘IP Portfolio Management – Aligning the Patent Portfolio with Business Goals’:

Intellectual property (IP) rights are completely worthless if they are not aligned with a company’s commercially relevant goals. Many companies are aware of the importance of IP rights. Thus, IP is now used not only to protect against imitation, but also as an attractive means to increase the value of a company. It is important here that the IP portfolio is aligned with the company’s orientation. What should I pay attention to in my IP strategy? How can I best adapt this strategy?

 

 

Latest updates

Polymorphs: Clearing the Inventive Step Hurdle at the European Patent Office (EPO)

Polymorphic forms of active pharmaceutical ingredients (APIs) can represent commercially valuable compound subject matter and can be critical to providing necessary drug product characteristics and performance. However, patenting polymorphs is …

Read article

IQPC Global US Exchange

HGF are proud ‘Silver Plus’ sponsors of the IQPC Global US Exchange, at the Austin Marriot South, Texas. The IQPC Global US Exchange will be held at the Austin Marriot …

Read article

Update on the Precision Breeding Act 2023: details emerge of the new simplified regulatory pathway for gene edited plant and animal derived food and feed products

The Genetic Technology (Precision Breeding) Act 2023 could come into force as early as spring 2025. It empowers the Food Standards Agency (FSA) to create a new simplified regulatory pathway …

Read article

Court of Appeal Decision Upholds Invalidity of Patent Due to Amendment Identifying Embodiment as Outside the Scope of the Claims

In a case that highlights the challenges arising due to post-grant amendments, and in particular interpretation of the claims in view of the description, the Court of Appeal in Ensygnia …

Read article

UPC Court of Appeal clarifies approach for interpreting claims with “obvious” errors

Alexion Pharmaceuticals, Inc. v Samsung Bioepis NL B.V. [UPC_CoA_402/2024] –Court of Appeal of the UPC (Grabinski, Blok, Gougé, Enderlin, Hedberg) – 20 December 2024 Alexion Pharmaceuticals, Inc. v Amgen Technology …

Read article

IP Ingredients: Winter Case Law Review 2024

As the nights draw in and the frenzy to finish everything off before the holiday season reaches its peak, it’s time to take a break, grab your favourite hot beverage …

Read article